Foley Hoag Advises Lead Investor in $36M Financing Round for TransMedics, Inc.
November 30, 2012
Foley Hoag LLP represented Abrams Capital in its $36 million investment in TransMedics, Inc., the global leader in organ preservation technology.
Abrams Capital is a Boston-based investment firm founded in 1999 that currently manages $5.7 billion. The firm’s investment strategy is opportunistic and follows a fundamental, value-oriented approach. The firm and its affiliates have acquired and liquidated profitable investments across a wide spectrum of investment types, investment strategies, market sectors, market cycles and industries. The investment in TransMedics will further the company’s mission of extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure through their Organ Care System (OCS™) Heart and Lung devices, which maintain donor organs in a near-physiologic and functioning condition from donor to transplant recipient.
The Foley Hoag team that advised Abrams Capital on the transaction included Mark Haddad and Amanda Vendig. The investment was supported by existing investors Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
